Recent developments for Selectis Health include multiple facility sales in Georgia, key leadership appointments, and financial results reporting, reflecting active portfolio management and organizational changes.

• Selectis Health entered a definitive purchase and sale agreement for Sparta and Warrenton transitional care facilities in Georgia, marking a significant organizational milestone in late 2025 [N1].
• The company made key leadership announcements in October 2024 and December 2023, indicating changes in management and board composition [N2][N4].
• Selectis Health entered a definitive purchase and sale agreement for the Archway Transitional Care Center in Georgia in May 2024 [N3].
• The company entered agreements to sell four skilled nursing facilities in Georgia in December 2023, reflecting portfolio adjustments [N5].
• Selectis Health reported third quarter 2022 financial results in January 2023, providing operational and financial updates [N6].
• The company presented at the Rocky Mountain Microcap Conference in November 2022 and appointed Andrew Sink to its Board of Directors in October 2022 [N7][N8].

Selectis Health’s transition to an owner-operator model enhances revenue visibility by capturing healthcare service income beyond rental payments. The company’s diversified portfolio across senior housing and skilled nursing facilities in the Southern U.S. provides exposure to growing healthcare demand driven by aging demographics. Recent sales of certain facilities may improve capital allocation and operational focus. Leadership appointments and strategic initiatives indicate active management aiming to improve operational efficiency and shareholder value. Conservative financing and debt repayment actions support financial stability. The company’s adherence to quality care standards and regulatory compliance may strengthen its reputation and operational performance.

Selectis Health faces liquidity constraints as indicated by a low current ratio and cash ratio as of December 31, 2025, which may limit operational flexibility. The company reported a net loss and negative EPS for fiscal 2025, reflecting ongoing profitability challenges. The healthcare real estate and operations sector is highly competitive, with risks from regulatory changes, reimbursement rate pressures, and operator financial health. The company’s recent sales of multiple facilities could signal portfolio contraction or challenges in maintaining occupancy and profitability. Exposure to government reimbursement programs subjects the company to policy and payment risks. Litigation and operational risks related to patient care also pose potential financial impacts. These factors may constrain growth and financial performance.

Selectis Health’s moat is based on its integrated model combining healthcare real estate ownership with direct healthcare operations, allowing control over quality and revenue streams. Its diversified portfolio across senior housing and skilled nursing facilities in multiple geographic locations reduces concentration risk. The company’s operational focus on quality care aligned with regulatory standards supports competitive positioning. However, the healthcare real estate and operations sector is highly competitive with many institutional players, and regulatory and reimbursement risks remain significant. The company’s ability to maintain diversified investments and conservative financing contributes to its resilience but does not create a strong barrier to entry.

• Liquidity Risk: The company’s current ratio of 0.3 and cash ratio of 0.04 as of December 31, 2025, indicate limited short-term liquidity, which may affect its ability to meet obligations and invest in growth.
• Regulatory and Reimbursement Risk: Selectis Health operates in a heavily regulated healthcare environment with significant dependence on Medicare and Medicaid reimbursements, which are subject to changes in government policy and payment rates that could adversely impact financial results.
• Operational Risk: The company’s healthcare operations face risks related to quality of care, staffing, and compliance with complex federal, state, and local regulations, which could result in sanctions, litigation, or reputational damage.
• Competitive Risk: The healthcare real estate and operations market is highly competitive with many institutional and private players, potentially limiting Selectis Health’s ability to acquire properties or maintain occupancy and profitability.
• Financial Performance Risk: The company reported a net loss and negative earnings per share for fiscal 2025, indicating challenges in achieving profitability and sustainable cash flow.

• Selectis Health, Inc. owns and operates assisted living, independent living, and skilled nursing facilities primarily in the South and Southeastern U.S. through wholly-owned subsidiaries.
• The company shifted in 2019 from leasing long-term care facilities to third-party operators towards an owner-operator model.
• As of December 31, 2025, Selectis owned 12 healthcare facilities and operated 9 through subsidiaries; after selling two facilities in January 2026, it operates 7 facilities.
• The company’s portfolio includes senior housing (independent and assisted living) and post-acute/skilled nursing operations.
• Selectis Health’s investment approach includes direct ownership, debt investments, developments and redevelopments, investment management, RIDEA structures, and owning healthcare operations.
• The company’s healthcare operations revenue mix has shifted from rental income to healthcare provision revenue.
• Selectis Health’s operational teams maintain quality care standards aligned with CDC, ADA, CMS, and state/local guidelines.
• The company’s investment strategy is based on quality healthcare, opportunistic investing, portfolio diversification, and conservative financing.
• Selectis Health faces competition from REITs, investment companies, private equity, sovereign funds, healthcare operators, lenders, and developers.
• The company’s healthcare operations include skilled nursing facilities offering rehabilitative and custodial care, independent living facilities for seniors, assisted living facilities providing personal care, and continuing care retirement communities.
• Revenue from healthcare operations is primarily from government programs (Medicare, Medicaid) and private pay sources.
• The company’s debt obligations are primarily fixed rate with staggered maturities to mitigate interest rate risk.
• Selectis Health has renegotiated senior secured notes multiple times, with the latest maturity extended to February 28, 2026, and the notes were repaid in full in January 2026.
• The company has commercial lines of credit with Southern Bank, with balances and availability disclosed as of December 31, 2025.
• As of December 31, 2025, Selectis had cash and equivalents of approximately $1.0 million, current assets of $7.58 million, and current liabilities of $25.27 million, resulting in a current ratio of 0.3 and a cash ratio of 0.04.
• Selectis Health completed sales of multiple skilled nursing and transitional care facilities in Georgia between 2024 and early 2026, including Sparta, Warrenton, and Archway facilities.
• The company made key leadership appointments and announcements in 2023 and 2024.
• Selectis Health’s business is subject to extensive federal, state, and local healthcare regulations, including fraud and abuse laws, reimbursement rules, and licensing requirements.
• The company maintains general and professional liability insurance to cover potential claims related to patient care.
• Selectis Health had a net loss of approximately $1.02 million and basic and diluted EPS of -$0.34 for the fiscal year ended December 31, 2025.
• The company’s revenue figure from the latest available quarter (Q3 2019) was approximately $1.99 million.
• Selectis Health’s business strategy emphasizes increasing shareholder value through profitable growth and professional healthcare provision.
• The company’s portfolio diversification strategy includes diversification by operational type, geography, operator, tenant, and product.
• Selectis Health’s liquidity position as of December 31, 2025, shows limited short-term liquidity with a current ratio below 1, indicating potential liquidity constraints.